# TIP-51 Provider Evidence Authorization Packet Trial Planning Brief v0.1

**File:** `docs/tips/tip_51_provider_evidence_authorization_packet_trial_planning/tip_51_planning_brief_v0_1.md`
**Version:** 0.1
**Status:** Draft - docs-only / provider-neutral / trial packet planning only
**Date:** 2026-06-20
**Baseline:** `1df2624598e25971c3d143c68aa995d6f5c97858 docs: close TIP-50 evidence authorization packet planning`
**Purpose:** Use the provider-neutral packet framework from TIP-50 to define and stress-test a trial Provider Evidence Authorization Packet shape for future provider-specific evidence collection decisions, while approving no packet and authorizing no provider-specific evidence collection.

## Changelog

### v0.1 - Initial provider-neutral trial packet planning draft

- Opened TIP-51 as docs-only provider-neutral trial packet planning.
- Defined a trial Provider Evidence Authorization Packet shape using placeholders only.
- Added a stress-test matrix and decision rules for the trial shape.
- Assessed the TIP-50 packet framework for planning gaps without patching TIP-50.
- Preserved default denial for provider-specific evidence collection, raw payload handling, artifact/raw evidence persistence, restricted artifact access, runtime implementation, provider/storage/resolver/tool selection, and readiness/legal/audit/security/production claims.

## 1. Status / Purpose / Non-Authorization

TIP-51 is docs-only, provider-neutral, and limited to trial packet planning.

TIP-51 uses the TIP-50 Provider Evidence Authorization Packet framework as a planning object. It drafts a trial packet shape and stress-tests that shape against expected future requests so later work can see which fields, dependency gates, and STOP/RRI triggers are required before any actual provider-specific evidence collection decision could be considered.

TIP-51 explicitly does not authorize:

- any actual packet approval;
- provider naming, comparison, scoring, shortlisting, recommendation, selection, acceptance, or rejection;
- provider-specific evidence collection;
- raw payload collection or persistence;
- artifact/raw evidence persistence;
- restricted artifact access;
- runtime implementation;
- source, test, project, package, schema, migration, API, DTO, adapter, resolver, storage, package-builder, tool, or runtime changes;
- HLD/LLD patches;
- provider, storage, resolver, tool, package, schema, API, or runtime selection;
- readiness, capability, legal, audit, security, production, pilot, certification, or support claims.

## 0. Repo Evidence

| Evidence | Current finding |
| --- | --- |
| Repository root | `D:/Task/Remote Signing/TagEkyc` |
| Current branch | `master` |
| Current HEAD before TIP-51 | `1df2624598e25971c3d143c68aa995d6f5c97858 docs: close TIP-50 evidence authorization packet planning` |
| TIP-50 closeout baseline | `1df2624598e25971c3d143c68aa995d6f5c97858 docs: close TIP-50 evidence authorization packet planning` |
| HLD/LLD files patched by TIP-49, context only | `docs/tagekyc_hld_v0_1.md`, `docs/lld_01_data_model_v0_1.md` |
| Known dirty out-of-scope files | `.gitignore`, `docs/00_AGENT_COORDINATION_BUS.md` |
| Intended planning commit changed files only | `docs/tips/README.md`, `docs/tips/tip_51_provider_evidence_authorization_packet_trial_planning/tip_51_planning_brief_v0_1.md` |
| Intended closeout commit changed files only | `docs/tips/README.md`, `docs/tips/tip_51_provider_evidence_authorization_packet_trial_planning/tip_51_closeout_v0_1.md` |

### Discovery Notes

TIP-50 closed with a provider-neutral evidence authorization packet framework. TIP-51 tests one trial Provider Evidence Authorization Packet shape against that framework without approving the shape as an actual packet.

TIP-49 patched HLD/LLD documentation as design requirements only. TIP-51 treats those files as context and does not patch them.

Known dirty files remain out of scope and must remain unstaged.

## 2. TIP Analytical Summary / Intent Ledger

### Intent

Create a provider-neutral trial shape for a future Provider Evidence Authorization Packet and stress-test whether the TIP-50 framework exposes the required dependencies and denial conditions.

### Expected Outcome

After TIP-51, future work has a trial packet shape, stress-test matrix, outcome classification set, and gap assessment for provider evidence authorization planning. The result may classify only the trial framework result; it must not approve a packet or authorize provider-specific evidence collection.

### Accepted Decisions

| Decision | Why accepted | Scope impact | Non-claims |
| --- | --- | --- | --- |
| Define a trial packet shape, not an approved packet. | TIP-50 provides a framework that should be exercised before any actual packet is opened. | Produces a reusable planning shape. | No packet approval. |
| Use placeholders only. | Provider names and provider-specific facts are forbidden in this TIP. | Keeps the trial provider-neutral. | No provider comparison, selection, acceptance, or rejection. |
| Keep every sensitive posture denied in trial. | Trial planning must not become evidence authorization. | Provider-specific collection, raw payload handling, persistence, and restricted access remain denied. | No provider evidence authorization. |
| Include `GOV-001` and `ART-001` through `ART-009` as dependency gates. | Prior TIPs require every evidence action to carry these gates visibly. | Trial packet exposes unresolved dependencies. | No GOV/ART gate is resolved by TIP-51. |
| Add a stress-test matrix. | The trial must prove the framework catches forbidden or missing inputs. | Records expected decision behavior. | No runtime or evidence claim. |
| Record framework gaps only as planning gaps. | TIP-51 must not patch TIP-50 or compensate by approving anything. | Carries gap findings forward. | No framework approval beyond trial classification. |

### Rejected / Deferred Branches

| Branch / option | Disposition | Why | Follow-up debt/gate |
| --- | --- | --- | --- |
| Approve the trial packet as an actual packet. | Rejected. | TIP-51 is trial packet planning only. | Later reviewed packet required. |
| Authorize provider-specific evidence collection. | Rejected. | `ART-009` remains a hard blocker and no actual packet exists in TIP-51. | Later reviewed Provider Evidence Authorization Packet required. |
| Authorize raw payload collection or persistence. | Rejected. | TIP-38 and TIP-50 keep raw payload handling denied by default. | Later reviewed packet plus dependency gates required before any exception can be considered. |
| Authorize artifact/raw evidence persistence. | Rejected. | `ART-001` remains packet-gated. | Later reviewed storage authorization packet required. |
| Authorize restricted artifact access. | Rejected. | `ART-007` remains packet-gated. | Later reviewed access/audit/security packet required. |
| Patch TIP-50 framework. | Deferred. | TIP-51 may identify framework gaps but must not patch TIP-50 in this run. | Carry gaps in TIP-51 and README. |
| Patch HLD/LLD files or runtime/source/test files. | Rejected. | Out of docs-only trial planning scope. | Later reviewed TIP required. |

### Debt / Gap Impact

| Debt/gap | TIP-51 action | Result | Carry-forward gate |
| --- | --- | --- | --- |
| `GOV-001` Branch/deferred-scope debt traceability | Include as dependency gate and STOP/RRI trigger. | Remains unresolved beyond carry-forward. | STOP/RRI if omitted or treated as resolved. |
| `ART-001` Artifact/raw evidence storage boundary | Require explicit denied posture for artifact/raw evidence persistence. | No persistence authorization. | Reviewed storage authorization packet. |
| `ART-002` Durable metadata reference resolution | Require dependency gate for any reference reliance. | No evidence availability proof. | Reviewed reference resolution packet. |
| `ART-003` Evidence package object completeness | Require non-success when completeness is claimed without packet support. | No package completeness proof. | Reviewed package completeness packet. |
| `ART-004` Artifact retention / expiry policy | Require dependency gate before retained/unexpired/reviewable reliance. | No retention/expiry reliance. | Reviewed retention/expiry packet. |
| `ART-005` Artifact purge / disposal workflow | Require dependency gate before disposal/tombstone/reference invalidation reliance. | No disposal reliance. | Reviewed purge/disposal packet. |
| `ART-006` Artifact legal-hold sync | Require unresolved conflict handling. | No authoritative hold-state reliance. | Reviewed legal-hold sync packet. |
| `ART-007` Artifact access/audit/security | Require denied restricted access posture in trial. | No restricted access or access/audit/security reliance. | Reviewed access/audit/security packet. |
| `ART-008` Metadata-artifact orphan handling | Require orphan-risk non-success behavior. | No orphan-risk evidence success. | Reviewed orphan handling packet. |
| `ART-009` Provider raw payload policy | Require provider-specific collection and raw payload postures to be denied in trial. | No provider-specific evidence or raw payload authorization. | Later actual Provider Evidence Authorization Packet required. |

### Non-Claims

TIP-51 does not approve any packet, authorize provider-specific evidence collection, authorize raw payload handling, authorize artifact/raw evidence persistence, authorize restricted artifact access, select provider/storage/resolver/tool, claim readiness/legal/audit/security/production/certification/capability, or resolve `GOV-001` or `ART-001` through `ART-009` beyond trial planning.

### Dispatch Posture

Implementation dispatch = NO.

Allowed files for TIP-51 are limited to:

- `docs/tips/README.md`
- `docs/tips/tip_51_provider_evidence_authorization_packet_trial_planning/tip_51_planning_brief_v0_1.md`
- `docs/tips/tip_51_provider_evidence_authorization_packet_trial_planning/tip_51_closeout_v0_1.md`

## 3. Source Map

| Source | Use in TIP-51 |
| --- | --- |
| `docs/tips/tip_35_s2_branch_debt_traceability_artifact_gap_registration/tip_35_closeout_v0_1.md` | Source for `GOV-001` and `ART-001` through `ART-009` registration. |
| `docs/tips/tip_36_tip_analytical_summary_intent_ledger_governance/tip_36_closeout_v0_1.md` | Source for analytical summary, intent ledger, branch disposition, and closeout reconciliation rules. |
| `docs/tips/tip_37_s3_provider_decision_evidence_scope_gov_art_gate_carry_forward/tip_37_closeout_v0_1.md` | Source for S3 evidence-scope carry-forward and provider evidence hard blocker posture. |
| `docs/tips/tip_38_provider_raw_payload_policy_planning/tip_38_closeout_v0_1.md` | Source for `ART-009` raw payload policy and raw payload default denial. |
| `docs/tips/tip_39_artifact_raw_evidence_storage_boundary_planning/tip_39_closeout_v0_1.md` | Source for `ART-001` storage boundary and storage authorization packet requirement. |
| `docs/tips/tip_40_durable_metadata_reference_resolution_planning/tip_40_closeout_v0_1.md` | Source for `ART-002` reference resolution and non-proof posture. |
| `docs/tips/tip_41_metadata_artifact_orphan_handling_planning/tip_41_closeout_v0_1.md` | Source for `ART-008` orphan handling and non-success behavior. |
| `docs/tips/tip_42_evidence_package_object_completeness_planning/tip_42_closeout_v0_1.md` | Source for `ART-003` package completeness gating. |
| `docs/tips/tip_43_artifact_retention_expiry_policy_planning/tip_43_closeout_v0_1.md` | Source for `ART-004` retention/expiry gating. |
| `docs/tips/tip_44_artifact_purge_disposal_workflow_planning/tip_44_closeout_v0_1.md` | Source for `ART-005` purge/disposal gating. |
| `docs/tips/tip_45_artifact_legal_hold_sync_planning/tip_45_closeout_v0_1.md` | Source for `ART-006` legal-hold sync and conflict handling. |
| `docs/tips/tip_46_artifact_access_audit_security_planning/tip_46_closeout_v0_1.md` | Source for `ART-007` access/audit/security denial and packet requirement. |
| `docs/tips/tip_47_gov_art_s3_evidence_gate_recheck_consolidation_planning/tip_47_closeout_v0_1.md` | Source for GOV/ART consolidation status after TIP-38 through TIP-46. |
| `docs/tips/tip_48_provider_neutral_artifact_evidence_hld_lld_consolidation_planning/tip_48_closeout_v0_1.md` | Source for HLD/LLD consolidation requirements and packet/checklist expectations. |
| `docs/tips/tip_49_provider_neutral_artifact_evidence_hld_lld_patch/tip_49_closeout_v0_1.md` | Source for HLD/LLD patch baseline and design-requirement-only posture. |
| `docs/tips/tip_50_provider_neutral_evidence_authorization_packet_planning/tip_50_closeout_v0_1.md` | Source for provider-neutral packet framework, templates, dependency ordering, and decision matrix. |
| `docs/tips/README.md` | TIP index update target and current TIP status source. |
| `docs/00_REVIEW_AND_TIP_PLAYBOOK.md` | Review playbook source for intent ledger, subagent review, closeout reconciliation, and STOP/RRI handling. |

## 4. Definitions

| Term | Definition |
| --- | --- |
| Provider evidence authorization packet trial | A docs-only exercise that tests whether a provider-neutral packet shape exposes required dependencies, forbidden inputs, and non-success outcomes before any actual provider evidence authorization request exists. |
| Trial packet | A planning artifact with placeholders only. It is not an approved packet and cannot authorize evidence collection or use. |
| Provider-neutral trial scope | A scope that describes categories, classifications, purposes, and gates without naming, comparing, scoring, selecting, accepting, or rejecting any provider. |
| Provider-specific evidence collection | Any collection, request, ingestion, sampling, storage, or review of evidence tied to an actual provider, provider account, provider response, provider fixture, provider portal, provider API, or provider-provided sample. TIP-51 authorizes none. |
| Evidence authorization request | A future reviewed request to permit a narrow classified evidence action. TIP-51 only defines trial request shape and denial behavior. |
| Evidence collection boundary | The line between allowed documentation-only planning text and prohibited evidence collection, raw payload handling, persistence, or restricted access. |
| Provider raw payload | Provider-originated bytes, response bodies, media, document images, biometric material, logs, exports, attachments, or payload fields before approved minimization and redaction. |
| Provider-derived metadata | Non-raw metadata derived from provider-originated material. It is not evidence availability proof in TIP-51 and cannot be relied on unless a later packet permits narrow use. |
| Sanitized provider summary | Generic, non-provider-specific documentation text that describes requirements or categories after redaction and without provider names, samples, identifiers, or payload values. |
| Redaction requirement | A mandatory rule that removes provider names, identifiers, raw payload values, secrets, retrieval-bearing references, and provider-specific sample content before documentation-only use. |
| No-provider-name placeholder | A neutral placeholder such as `[PROVIDER_CATEGORY_PLACEHOLDER]` or `[PROVIDER_EVIDENCE_CATEGORY]` that does not identify an actual provider. |
| Trial failure condition | Any condition that forces `NOT_AUTHORIZED`, `TRIAL_SHAPE_STOP_RRI`, or `FRAMEWORK_GAP_FOUND` instead of accepting the trial shape. |
| Packet framework gap | A missing field, dependency, decision rule, invalidation trigger, or non-success condition in the TIP-50 framework discovered by applying the trial shape. |

## 5. Default Posture

- TIP-51 trial packet is not an approved packet.
- Provider-specific evidence collection remains denied by default.
- Provider names are forbidden.
- Raw provider payload collection/persistence remains denied by default.
- Artifact/raw evidence persistence remains denied by default.
- Restricted artifact access remains denied by default.
- Provider-derived metadata and sanitized summaries are not evidence availability proof unless a later packet permits narrow use.
- Trial packet shape must expose dependencies, not satisfy them.
- HLD/LLD docs and packet templates are not runtime or provider evidence authorization.
- Planning text cannot compensate for an unresolved packet dependency.
- Missing dependency status is non-success, not implied permission.

## 6. Trial Provider Evidence Authorization Packet Shape

This shape is a trial planning shape only. It is not an approved packet.

| Field | Trial requirement |
| --- | --- |
| Packet ID | `TRIAL-PEAP-[NN]` or equivalent provider-neutral identifier. |
| Purpose | Describe why a future provider evidence authorization request might be reviewed, without approving it. |
| Provider category placeholder, not provider name | Use only `[PROVIDER_CATEGORY_PLACEHOLDER]`; provider names are forbidden. |
| Evidence category placeholder | Use `[EVIDENCE_CATEGORY_PLACEHOLDER]`; do not include provider-specific samples. |
| Data classification | Classify the hypothetical evidence category and identify whether raw, restricted, derived, or sanitized data would be involved. |
| Intended evidence use | State the proposed future use as a question, not permission. |
| Explicit forbidden uses | Forbid provider selection, scoring, comparison, acceptance, rejection, runtime implementation, raw payload handling, persistence, restricted access, readiness claims, and package completeness claims. |
| Provider-specific evidence collection request | `DENIED_IN_TRIAL`. No collection may occur in TIP-51. |
| Raw payload posture | `DENIED_IN_TRIAL`. Raw payload collection and persistence remain denied. |
| Artifact/raw evidence persistence posture | `DENIED_IN_TRIAL`. No artifact/raw evidence persistence is authorized. |
| Restricted artifact access posture | `DENIED_IN_TRIAL`. No restricted artifact access is authorized. |
| Allowed documentation-only evidence, if any | Sanitized non-provider-specific requirements only, with no provider names, provider identifiers, payload values, samples, screenshots, exports, logs, or retrieval-bearing references. |
| Dependency gates | Must list `GOV-001` and `ART-001` through `ART-009` with status: satisfied, unresolved, carried, denied, or not applicable. In TIP-51, sensitive gates remain unresolved/carried or denied. |
| Required reviewer record | Must record reviewer role, review date, packet version, dependency status, redaction result, decision classification, and STOP/RRI result. TIP-51 records an internal reviewer only for the trial planning docs. |
| Redaction requirements | Remove provider names, identifiers, raw values, secrets, samples, screenshots, exports, logs, retrieval-bearing references, and provider-specific capability statements. |
| Non-success conditions | Missing dependency, provider name, provider-specific sample, raw payload request, persistence request, restricted access request, runtime request, HLD/LLD-as-authorization, comparison/scoring/selection, or readiness claim. |
| Invalidation criteria | Any later discovery of provider-specific content, raw payload content, unresolved dependency hidden by the packet, changed GOV/ART gate, stale reviewer record, or framework field gap. |
| Revalidation triggers | Dependency gate change, evidence category change, data classification change, reviewer boundary change, redaction rule change, scope expansion, or any STOP/RRI event. |
| STOP/RRI triggers | Provider name, comparison/scoring/selection, provider-specific evidence request, raw payload request, artifact/raw persistence request, restricted access request, runtime request, HLD/LLD-as-authorization, readiness claim, missing critical dependency, or framework ambiguity. |
| Trial outcome classification | One of `TRIAL_SHAPE_ACCEPTED`, `TRIAL_SHAPE_NEEDS_PATCH`, `TRIAL_SHAPE_STOP_RRI`, `FRAMEWORK_GAP_FOUND`, or `NOT_AUTHORIZED`. |

### Dependency Gate Template

| Gate | Trial packet treatment |
| --- | --- |
| `GOV-001` | Must be carried or explicitly resolved by later reviewed work; TIP-51 does not resolve it. |
| `ART-001` | Persistence denied in trial; storage authorization packet required before any persistence. |
| `ART-002` | Reference reliance denied in trial; reference resolution packet required before evidence availability reliance. |
| `ART-003` | Package completeness denied in trial; package completeness packet required before completeness reliance. |
| `ART-004` | Retained/unexpired/reviewable reliance denied in trial; retention/expiry packet required before reliance. |
| `ART-005` | Disposal/tombstone/reference invalidation reliance denied in trial; purge/disposal packet required before reliance. |
| `ART-006` | Hold-state authority denied in trial; legal-hold sync packet required before reliance. |
| `ART-007` | Restricted access and access/audit/security reliance denied in trial; access/audit/security packet required before reliance. |
| `ART-008` | Orphan-risk success denied in trial; orphan handling packet required before reliance. |
| `ART-009` | Provider-specific evidence collection and raw payload handling denied in trial; later actual Provider Evidence Authorization Packet required before any exception can be considered. |

## 7. Trial Stress-Test Matrix

| Scenario | Expected decision | Why |
| --- | --- | --- |
| Provider name appears. | `TRIAL_SHAPE_STOP_RRI` | Provider names are forbidden and break provider-neutral trial scope. |
| Raw payload required. | `NOT_AUTHORIZED` / `TRIAL_SHAPE_STOP_RRI` | Raw payload collection and persistence remain denied by default under `ART-009`. |
| Provider-specific sample data requested. | `NOT_AUTHORIZED` / `TRIAL_SHAPE_STOP_RRI` | Provider-specific evidence collection is denied in trial. |
| Storage authorization missing. | `NOT_AUTHORIZED` | `ART-001` is required before artifact/raw evidence persistence can be considered. |
| Reference resolution missing. | `NOT_AUTHORIZED` | `ART-002` is required before references can support evidence availability reliance. |
| Access/audit/security missing. | `NOT_AUTHORIZED` | `ART-007` is required before restricted access or access/audit/security reliance. |
| Retention/expiry missing. | `NOT_AUTHORIZED` | `ART-004` is required before retained/unexpired/reviewable reliance. |
| Legal hold conflict unresolved. | `TRIAL_SHAPE_STOP_RRI` | `ART-006` unresolved conflict prevents evidence reliance or disposal movement. |
| Orphan handling missing. | `NOT_AUTHORIZED` | `ART-008` is required before orphan-risk references can support evidence or package positions. |
| Package completeness claimed. | `TRIAL_SHAPE_STOP_RRI` | `ART-003` is required and TIP-51 cannot claim complete package state. |
| Runtime implementation requested. | `TRIAL_SHAPE_STOP_RRI` | TIP-51 is docs-only and HLD/LLD/packet templates are not runtime authorization. |
| HLD/LLD treated as authorization. | `TRIAL_SHAPE_STOP_RRI` | TIP-49 HLD/LLD patches are design requirements only. |
| Only sanitized generic capability requirement text is present. | `TRIAL_SHAPE_ACCEPTED` if no forbidden content and all dependency gaps remain explicit; otherwise `TRIAL_SHAPE_NEEDS_PATCH`. | Sanitized non-provider-specific requirement text may be documentation-only input, but it proves no evidence availability or provider evidence permission. |
| Packet wants to authorize provider evidence collection. | `NOT_AUTHORIZED` / `TRIAL_SHAPE_STOP_RRI` | TIP-51 approves no packet and no actual reviewed packet exists. |

## 8. Required Outcome Classification

The trial packet may classify framework result only as:

- `TRIAL_SHAPE_ACCEPTED`
- `TRIAL_SHAPE_NEEDS_PATCH`
- `TRIAL_SHAPE_STOP_RRI`
- `FRAMEWORK_GAP_FOUND`
- `NOT_AUTHORIZED`

The trial packet must not classify as:

- `APPROVED`
- `AUTHORIZED`
- `READY`
- `PROVIDER_READY`
- `EVIDENCE_READY`
- `PRODUCTION_READY`

TIP-51 trial result:

```text
TRIAL_SHAPE_ACCEPTED
```

The result means the trial shape is internally usable for future planning discussion only. It does not approve any packet and does not authorize any provider-specific evidence collection.

## 9. Framework Gap Assessment

TIP-51 did not find a blocker gap in the TIP-50 framework for trial packet planning.

Planning observations carried forward:

| Observation | Assessment | Carry-forward |
| --- | --- | --- |
| TIP-50 includes common fields for scope, data classification, dependencies, raw payload posture, provider-specific evidence posture, reviewer record, invalidation, revalidation, and STOP/RRI conditions. | Sufficient for TIP-51 trial shape. | Future actual packets should instantiate these fields explicitly. |
| TIP-50 does not provide a fixed outcome classification vocabulary for trial packet exercises. | Non-blocking planning gap addressed in TIP-51 only. | Carry the TIP-51 classification set into any later trial packet work. |
| TIP-50 requires redaction and forbidden-use handling but does not prescribe exact placeholder names. | Non-blocking planning gap addressed in TIP-51 only. | Carry no-provider-name placeholder examples forward. |
| TIP-50 allows future packet evidence inputs but does not separately name sanitized generic requirement text. | Non-blocking planning gap addressed in TIP-51 only. | Carry the sanitized documentation-only evidence boundary forward. |

No TIP-50 patch is made in TIP-51. No approval is granted by compensating in TIP-51 text.

## 10. Decision Rules

- Any provider name => STOP/RRI.
- Any provider comparison/scoring/selection => STOP/RRI.
- Raw payload requested => `NOT_AUTHORIZED` / `TRIAL_SHAPE_STOP_RRI`.
- Artifact/raw persistence requested => `NOT_AUTHORIZED` / `TRIAL_SHAPE_STOP_RRI`.
- Restricted access requested => `NOT_AUTHORIZED` / `TRIAL_SHAPE_STOP_RRI`.
- Provider-specific evidence collection requested => `NOT_AUTHORIZED` unless a later actual reviewed packet exists; no such packet exists in TIP-51.
- HLD/LLD treated as authorization => STOP/RRI.
- Runtime requested => STOP/RRI.
- Readiness claimed => STOP/RRI.
- Missing dependency gate status => `TRIAL_SHAPE_NEEDS_PATCH` or STOP/RRI if the missing gate affects sensitive evidence use.
- Sanitized generic requirement text may remain only if it is non-provider-specific, redacted, documentation-only, and not treated as evidence availability proof.

## 11. Review Checklist

The internal reviewer must check:

- no provider names;
- no provider comparison/scoring/selection;
- no packet approval;
- no provider-specific evidence authorization;
- no raw payload/artifact persistence authorization;
- no restricted artifact access authorization;
- no runtime implementation authorization;
- no provider/storage/tool selection;
- no readiness/legal/audit/security/production/certification claims;
- TIP-50 framework is used correctly;
- HLD/LLD patch from TIP-49 is treated as design requirement only;
- README consistency;
- closeout Outcome vs Intent completeness.

## 12. Validation / Commit Plan

Planning validation:

```powershell
git diff --check
git diff --cached --check
git diff --cached --name-only
git status --short
```

Planning commit message:

```text
docs: open TIP-51 provider evidence authorization packet trial planning
```

Stage only:

- `docs/tips/README.md`
- `docs/tips/tip_51_provider_evidence_authorization_packet_trial_planning/tip_51_planning_brief_v0_1.md`

Closeout validation repeats the same commands before closeout commit.

Closeout commit message:

```text
docs: close TIP-51 provider evidence authorization packet trial planning
```

Stage only:

- `docs/tips/README.md`
- `docs/tips/tip_51_provider_evidence_authorization_packet_trial_planning/tip_51_closeout_v0_1.md`

Do not run `dotnet test` unless docs-only scope is violated.

## 13. Recommended Next Step

Based on the clean trial result, recommend either:

- Provider-Neutral Storage/Reference Runtime Slice Planning; or
- Provider Evidence Authorization Packet v0.1 Planning with explicit provider-neutral placeholders only.

Do not open the next TIP in this run.
